A new survey revealed that adults and caregivers of children aged 2-17 years living with atopic dermatitis (AD), commonly referred to as eczema, experience sleep disruptions attributed to the condition’s hallmark symptom of itching, which negatively impacts their mood, decreases daytime productivity and heightens stress levels.

AD, one of the most common chronic inflammatory skin diseases, affects over 26 million people in the U.S. alone and up to 10% of adults worldwide. AD occurs most frequently in children, affecting up to 20% worldwide.

The prevalence of atopic dermatitis, an extremely burdensome skin condition that negatively impacts the quality of life of patients suffering from AD and the families and caretakers of patients with AD, continues to grow. Dr. John Browning, a pediatric dermatologist, believes that patients need meaningful solutions that go beyond the surface of the skin. This survey underscores how adults with AD and caregivers of children ages 2-17 years with AD feel about the current treatment landscape and their understanding of concerns related to using topical steroids. It also aimed to explore the extent to which AD symptoms disrupt sleep and, consequently, affect daily functioning for both AD patients and their caregivers.

Key findings from the survey among adult patients with AD (n=502) and caregivers of children 2-17 with AD (n=510):
Itch is a top frustration that impacts patients’ and caregivers’ ability to get quality sleep.

89% of adult patients and caregivers of children aged 2-17 years with atopic dermatitis said itch is a top frustration from atopic dermatitis, and 94% said itching is the top symptom that disrupts sleep.

74% of adult patients and caregivers of children aged 2-17 years with atopic dermatitis stated that atopic dermatitis frequently or occasionally impacts their ability to get quality sleep, and 76% claim they have disrupted sleep an average of one to four nights per week.

These sleep disruptions have negative effects on mood (69%), daily routines (54%), daytime focus (51%), daytime productivity (51%) and stress (50%).

A majority of patients apply topicals before bed to ensure a good night’s sleep, however, patients and caregivers of children with AD have concerns about current treatment options.

72% of adult patients and caregivers of children aged 2-17 years with atopic dermatitis apply topicals before bed in an effort to ensure a good night’s sleep.

46% of caregivers of children aged 2-17 years with atopic dermatitis are extremely or very concerned about using topical steroids for their child’s atopic dermatitis.

Most patients and caregivers feel there should be a wider variety of treatment options.

Current topical treatments present issues that disrupt sleep, such as needing time to dry (58%), causing irritation (51%), and feeling uncomfortable (51%).

83% of adult patients and caregivers of children aged 2-17 years with atopic dermatitis said there is an unmet need in current atopic dermatitis treatment options.

Dr. Browning will discuss how itch (the hallmark symptom of atopic dermatitis), significantly disrupts sleep and the pressing need for new, long-term, treatment options to provide itch relief.

Interview is courtesy: Dermavant Sciences, Inc.
References available on request

#sleepawareness #march #sleeplessness #learnaboutcondition #johnbrowning #disruptions #impact #mood #productivity #stresslevels #dermavant #sciences #atopicdermatitis #ad

The post Sleep Awareness Month in March- Learn About Condition that Causes Sleeplessness appeared first on Good News!.

Current research suggests that a reduction in breast cancer screenings at the beginning of the COVID-19 pandemic may have contributed to fewer early-stage and more late-stage breast cancer diagnoses in 2020 (latest statistics available) than in 2019, according to a study published by the journal JAMA Network Open.3

Many people experienced delayed or cancelled mammograms because of the pandemic, and these disruptions may have contributed to later-stage breast cancer diagnoses, when the disease is more difficult to treat.3,4

While mammography screenings rebounded overall by July 2020, the cumulative deficit of missed mammograms may have important public health consequences,5 including the furthering of health disparities.6

Since 2021, breast cancer diagnoses have exceeded lung cancer diagnoses, becoming the most diagnosed cancer worldwide.7,8

In the United States, it is estimated that about 287,850 women in 2022 will be diagnosed with breast cancer.9 Breast cancer is the most commonly diagnosed cancer among women in the U.S., and this year it’s estimated that about 30% of all newly diagnosed cancers in women will be breast cancers.10

For those facing a breast cancer diagnosis, the treatment that follows can be challenging and time consuming. Additionally, the type of breast cancer a patient has — including triple negative, HER2+ or HR+ — impacts the type of treatment they’ll receive.

Dr. Ahmed Elkhanany, a breast cancer expert at the University of Alabama at Birmingham, will discuss the latest news surrounding delays in breast cancer screenings and some of the recent treatment options. A patient share her experience too.

Interview courtesy: Genentech

1 American Cancer Society. American Cancer Society Recommendations for the Early Detection of Breast Cancer. https://www.cancer.org/cancer/breast-cancer/screening-tests-and-early-detection/american-cancer-society-recommendations-for-the-early-detection-of-breast-cancer.html. Accessed June 9, 2022.
2 American Cancer Society. Survival Rates for Breast Cancer. https://www.cancer.org/cancer/breast-cancer/understanding-a-breast-cancer-diagnosis/breast-cancer-survival-rates.html. Accessed June 9, 2022.
3 Zhou J, et al. Comparison of Early- and Late-Stage Breast and Colorectal Cancer Diagnoses During vs Before the COVID-19 Pandemic. JAMA Network Open. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2789064. Accessed June 1, 2022.
4 Elek P, et al. Effects of lower screening activity during the COVID-19 pandemic on breast cancer patient pathways: Evidence from the age cut-off of organized screening. Health Policy. https://www.sciencedirect.com/science/article/pii/S0168851022001257?via%3Dihub. Accessed June 9, 2022.
5 Sprague B, et al. Changes in Mammography Utilization by Women’s Characteristics during the First 5 Months of the COVID- 19 Pandemic. JNCI. 29 March 2021. https://academic.oup.com/jnci/advance-article/doi/10.1093/jnci/djab045/6184869.
Accessed June 1, 2022.
6 DeGroff A, et al. COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January–June 2020, in the United States. Preventive Medicine. 2021. https://www.sciencedirect.com/science/article/pii/S0091743521001432?utm_campaign=11a0a4d458MR_COPY_02&utm_medium=email&utm_source=STAT+Newsletters&utm_term=0_8cab1d7961-11a0a4d458-153427414. Accessed June 1, 2022.
7 World Health Organization. Breast cancer now most common form of cancer: WHO taking action. https://www.who.int/news/item/03-02-2021-breast-cancer-now-most-common-form-of-cancer-who-taking-action. Accessed June 1, 2022.
8 International Agency for Research on Cancer. All-cancers fact-sheet. https://gco.iarc.fr/today/fact-sheets-cancers. Accessed June 10, 2022.
9 National Cancer Institute, The Surveillance, Epidemiology, and End Results (SEER). Cancer Stat Facts: Female Breast Cancer. https://seer.cancer.gov/statfacts/html/breast.html. Accessed June 10, 2022.
10 BreastCancer.org. U.S Breast Cancer Statistics. https://www.breastcancer.org/symptoms/understand_bc/statistics. Accessed June 10, 2022.

#breastcancer #ahmedelkhanany #pandemic #melissa #women #survivalrates #covid #delayed #cancelmammograms #cancelledmammograms #disruptions #genentech #screening #treatment #experience

The post DROP IN EARLY BREAST CANCER DIAGNOSES TIED TO PANDEMIC appeared first on Good News!.

It will be an immersive and interactive art experience with several executives and thought leaders sharing perspectives on the emerging new drivers of consumer demand, evolving workforce needs, the growth of the metaverse, and more. Inspired by Oliver Wyman Forum insights in Renaissance 2022: New People Shaping Our Future covering 18 months of research with 100,000+ human voices across 10 countries on the most pressing changes and trends emerging from the pandemic.

The evening will start with a private viewing of award-winning photographer Michelle Watt’s exhibition capturing the macro disruptions in art over hors d’oeuvres and drinks, followed by a discussion on the implications for businesses as we look to the future. An example of blue collar talent insights was recently featured in the “Wall Street Journal.”

https://www.oliverwymanforum.com/events/meet-the-new-people-shaping-our-future.html

#newthinkersdreamersdoers #shapingourfuture #oliverwyman #art #business #media #newyork #fotograiska #emerges #disruptions #pandemic #workforce #renaissance

The post The New Thinkers, Dreamers, and Doers Shaping Our Future appeared first on Good News!.